The Fda And Psychiatric Drugs
DOWNLOAD
Download The Fda And Psychiatric Drugs PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get The Fda And Psychiatric Drugs book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page
The Fda Psychiatric Drugs
DOWNLOAD
Author : Joan Esherick
language : en
Publisher: Simon and Schuster
Release Date : 2014-09-02
The Fda Psychiatric Drugs written by Joan Esherick and has been published by Simon and Schuster this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-09-02 with Juvenile Nonfiction categories.
Imagine taking a medication meant to heal you only to discover that the drug rotted your bones, made your teeth fall out, and filled you with a radioactive element called radium. Pittsburgh industrialist Eben Byers didn't have to imagine. It happened to him, and he died as a result. Mr. Byers fell victim to "patent medicines" sold in the early twentieth century. Patent medicine quackery and other medical tragedies prompted the United States government to form an agency that could protect patients and consumers from mislabeled or dangerous medicines, cosmetics, and foods. That agency is the U.S. Food and Drug Administration (FDA). Most drugs and medical treatments sold in North America today, including drugs used to treat psychological disorders, are regulated by this consumer protection agency. Many people diagnosed with depression, panic attacks, schizophrenia, ADHD, and other psychological disorders lead normal lives because they are treated with psychiatric drugs approved by the FDA. But what are psychiatric drugs? Where do they come from? How do they work? What does it take for the FDA to approve them? Why do we have the FDA? Perhaps most important, does FDA approval guarantee safety? Loaded with case studies and user-friendly illustrations, this readable text answers these and other questions as it examines a brief history of mental disorders and their treatment. In its pages, you will learn about the origins of the FDA, the FDA drug approval process, the structure and chemistry of the brain, psychiatric drugs and how they work, adverse reactions, and alternative treatments. Come learn about the drug approval process. Next time you reach into your medicine cabinet, you'll be glad you did.
The Fda And Psychiatric Drugs
DOWNLOAD
Author : Joan Esherick
language : en
Publisher:
Release Date : 2014
The Fda And Psychiatric Drugs written by Joan Esherick and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014 with Drug approval categories.
Imagine taking a medication meant to heal you only to discover that the drug rotted your bones, made your teeth fall out, and filled you with a radioactive element called radium. Pittsburgh industrialist Eben Byers didn't have to imagine. It happened to him, and he died as a result.
Psychiatric Disorders
DOWNLOAD
Author : Ann Vitale
language : en
Publisher:
Release Date : 2004
Psychiatric Disorders written by Ann Vitale and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2004 with Juvenile Nonfiction categories.
Describes how a psychiatric drug is approved for use by the FDA, as well as some historical background on the agency.
Brain Disabling Treatments In Psychiatry
DOWNLOAD
Author : Peter R. Breggin, MD
language : en
Publisher: Springer Publishing Company
Release Date : 2007-12-17
Brain Disabling Treatments In Psychiatry written by Peter R. Breggin, MD and has been published by Springer Publishing Company this book supported file pdf, txt, epub, kindle and other format this book has been release on 2007-12-17 with Medical categories.
From the author of Toxic Psychiatry and Talking Back to Prozac: "Peter Breggin is the conscience of American psychiatry. Once more he updates us on the real evidence with respect to the safety and effectiveness of specific psychiatric medications and ECT. This information is needed by all mental health professionals, as well as patients and families." --Bertram Karon, Ph.D., Professor of Psychology, Michigan State University, Author of The Psychotherapy of Schizophrenia "Nowhere does false medical thinking do more harm than in the modern psychiatric argument that mental illness is easily diagnosed and then cured by a side-effect free drug. Nowhere is the correct psychiatric thinking more evident than in the books by Peter Breggin."-- William Glasser, MD, psychiatrist, author of Reality Therapy In Brain Disabling Treatments in Psychiatry, renowned psychiatrist Peter R. Breggin, M.D., presents startling scientific research on the dangerous behavioral abnormalities and brain dysfunctions produced by the most widely used and newest psychiatric drugs such as Prozac, Paxil, Zoloft, Cymbalta, Effexor, Xanax, Ativan, Ritalin, Adderall, Concerta, Strattera, Risperdal, Zyprexa, Geodon, Abilify, lithium and Depakote. Many of Breggin's earlier findings have improved clinical practice, led to legal victories against drug companies, and resulted in FDA-mandated changes in what the manufacturers must admit about their drugs. Yet reliance on these drugs has continued to escalate in the last decade, and drug company interests have overwhelmed psychiatric practice. This greatly expanded second edition, supported by the latest evidence-based research, shows that psychiatric drugs achieve their primary or essential effect by causing brain dysfunction, and that they tend to do far more harm than good. New scientific analyses in this completely updated edition include: Chapters covering every new antidepressant and stimulant drug Twenty new guidelines for how to conduct non-drug therapy A chapter describing how to safely withdraw from psychiatric drugs A discussion of "medication spellbinding," explaining how patients fail to appreciate their drug-induced mental dysfunctions Documentation of how the drug companies control research and the flow of information about psychiatric treatments
Brain Disabling Treatments In Psychiatry
DOWNLOAD
Author : Peter Roger Breggin
language : en
Publisher:
Release Date : 1997
Brain Disabling Treatments In Psychiatry written by Peter Roger Breggin and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1997 with Medical categories.
Your Drug May Be Your Problem
DOWNLOAD
Author : Peter Breggin
language : en
Publisher: Hachette UK
Release Date : 2007-09-07
Your Drug May Be Your Problem written by Peter Breggin and has been published by Hachette UK this book supported file pdf, txt, epub, kindle and other format this book has been release on 2007-09-07 with Psychology categories.
When first published in 1999, Your Drug May Be Your Problem was ahead of its time. The only book to provide an uncensored description of the dangers involved in taking every kind of psychiatric medication, it was also the first and only book to explain how to safely stop taking them. In the time elapsed, there have been numerous studies suggesting or proving the dangers of some psychiatric medications and even the FDA now acknowledges the problems; more studies are under way to determine their long-term and withdrawal effects. In the meantime, this book continues to be ever relevant and helpful. Fully updated to include study results and new medications that have come to market, Your Drug May Be Your Problem will help countless readers exert control over their own psychiatric treatment.
Psychiatric Drugs In Children And Adolescents
DOWNLOAD
Author : Manfred Gerlach
language : en
Publisher: Springer
Release Date : 2014-06-26
Psychiatric Drugs In Children And Adolescents written by Manfred Gerlach and has been published by Springer this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-06-26 with Medical categories.
This book offers a comprehensive survey of the current state of knowledge in the field of neuro-psychopharmacology in childhood and adolescence. In the first part, the essentials of neuro-psychopharmacology are presented in order to provide a deeper understanding of the principles and particularities in the pharmacotherapy of children and adolescents. This part includes information on neurotransmitters and signal transduction pathways, molecular brain structures as targets for psychiatric drugs, characteristics of psychopharmacological therapy in children and adolescents, ontogenetic influences on pharmacokinetics and pharmacodynamics, and pharmacotherapy in the outpatient setting. The part on classes of psychiatric medications, which covers antidepressants, antipsychotics, anxiolytics and sedative-hypnotics, mood stabilizers, and psychostimulants and other drugs used in the treatment of attention-deficit/hyperactivity disorder, provides sufficient background material to better understand how psychoactive drugs work, and why, when, and for whom they should be used. For each drug within a class, information on its mechanisms of action, clinical pharmacology, indications, dosages, and cognate issues are reviewed. In the third part, the disorder-specific and symptom-oriented medication is described and discerningly evaluated from a practical point of view, providing physicians with precise instructions on how to proceed. Psychiatric Drugs in Children and Adolescents includes numerous tables, figures and illustrations and offers a valuable reference work for child and adolescent psychiatrists and psychotherapists, pediatricians, general practitioners, psychologists, and nursing staff, as well as teachers.
Psychotropic Drug Handbook
DOWNLOAD
Author : Paul J. Perry
language : en
Publisher: Lippincott Williams & Wilkins
Release Date : 2007
Psychotropic Drug Handbook written by Paul J. Perry and has been published by Lippincott Williams & Wilkins this book supported file pdf, txt, epub, kindle and other format this book has been release on 2007 with Medical categories.
This succinct handbook provides students and practitioners with clinically relevant psychotropic drug information. The Eighth Edition is designed as a reference text that also teaches by delivering informative narrative text under standard headlines with references. Its focus goes beyond drug information to cover pharmacotherapy applications. The book provides detailed, well-referenced, evidence-based information on a wide range of psychotropic drugs, including mood stabilizers, antidepressants, and antianxiety agents. This edition has new chapters on pediatric and geriatric psychopharmacotherapy; new content on antipsychotics, hypnotics, medications used in treating alcoholism and substance dependence, and electroconvulsive therapy; and new algorithms, appendices, and tables.
Talking Back To Prozac
DOWNLOAD
Author : Peter R. Breggin
language : en
Publisher: Open Road Media
Release Date : 2014-04-01
Talking Back To Prozac written by Peter R. Breggin and has been published by Open Road Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-04-01 with Psychology categories.
A psychiatrist takes a critical look at this SSRI and newer medications that are among the most frequently prescribed drugs in America. Prozac. Millions of Americans are on it. And just about everyone else is wondering if they should be on it, too. The claims of the pro‐Prozac chorus are enticing: that it can cure everything from depression (the only disorder for which Prozac was originally approved) to fear of public speaking, PMS, obesity, shyness, migraine, and back pain—with few or no side effects. But is the reality quite different? At what price do we buy Prozac‐induced euphoria and a shiny new personality? Psychiatrist Peter Breggin, MD, and coauthor Ginger Ross Breggin answer these and other crucial questions in Talking Back to Prozac. They explain what Prozac is and how it works, and they take a hard look at the real story behind today’s most controversial drug: The fact that Prozac was tested in trials of four to six weeks in length before receiving FDA approval The difficulty Prozac’s manufacturer had in proving its effectiveness during these tests The information on side effects that the FDA failed to include in its final labeling requirements How Prozac acts as a stimulant not unlike the addictive drugs cocaine and amphetamine The dangers of possible Prozac addiction and abuse The seriousness and frequency of Prozac’s side effects, including agitation, insomnia, nausea, diarrhea, loss of libido, and difficulty reaching orgasm The growing evidence that Prozac can cause violence and suicide The social and workplace implications of using the drug not to cure depression but to change personality and enhance performance Using dramatic case histories as well as scientific research and carefully documented evidence, the Breggins expose the potentially damaging effects of Prozac. They also describe the resounding success that has been achieved with more humane alternatives for the treatment of depression. Talking Back to Prozac provides essential information for anyone who takes Prozac or is considering taking it, and for those who prescribe it.
Psychopharmacology
DOWNLOAD
Author : Arash Ansari
language : en
Publisher: Oxford University Press
Release Date : 2020-08-18
Psychopharmacology written by Arash Ansari and has been published by Oxford University Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-08-18 with Medical categories.
Psychopharmacology: A Concise Overview, 3rd Edition is an evidence-based overview of the major classes of psychiatric medications and their use in clinical practice. Clinical considerations as to when, why, and how to use each individual medication are discussed in depth, as are relevant clinical controversies and treatment caveats. Each chapter also features an updated table of individual medications and their generic and brand names, dosing information, pertinent clinical comments, black box warnings, and Food and Drug Administration indications. This overview will equip readers with an essential framework of the concepts of psychopharmacology in an accessible length and style ideal for use as either a primer or refresher text. Medical students, residents, practicing physicians, nurse practitioners and other prescribers, as well as non-prescribing mental health clinicians who need to have a functional familiarity with available pharmacotherapies, will benefit from reading this concise book.